Myrexis

Myrexis Goodwill

Goodwill of Myrexis (MYRX) as of Oct 18, 2026.

Goodwill

-USD

Last updated:

Goodwill of Myrexis is 2026 - USD. Goodwill of Myrexis was 2025 - USD. It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Myrexis Stock analysis

What does Myrexis do? Myrexis Inc., based in New York City, operates in the Health Care sector with a focus on Biotechnology. The company evaluates strategic alternatives, including financial investments in life sciences assets, and previously developed drug candidates in oncology and autoimmune diseases. It suspended clinical development in 2012 and aims to build a commercial-stage biopharmaceutical company. Myrexis employs one full-time employee and conducts research and development activities primarily within the United States. Myrexis is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Myrexis stock

On Eulerpool you can find the complete historical development of Goodwill Myrexis since 2006 – with annual values, charts, and detailed analysis.

Goodwill is the premium paid above fair market value in an acquisition. It represents intangible value such as brand recognition, customer relationships, and intellectual property.

Goodwill's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Goodwill's Myrexis historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Myrexis

All Key Metrics — Myrexis